To investigate the presence of PLAG1 rearrangements and MYC amplification in sporadic cardiac myxomas (SCM) to understand their molecular pathogenesis and potential clinical implications.
Key Findings:
PLAG1 break-apart signals were detected in 35.7% (5/14) of SCM cases, indicating a potential role in tumorigenesis.
Atypical isolated signals for PLAG1 were observed in 64.3% and 85.7% of cases, suggesting possible unbalanced translocations or copy number variations.
No MYC amplification was found in any SCM cases, reinforcing the benign nature of these tumors.
Statistical analysis supported a >0.5% threshold for PLAG1 Break-Apart, indicating its potential as a diagnostic marker.
Interpretation:
The presence of PLAG1 rearrangements in a subset of SCMs suggests potential molecular similarities with other tumors featuring abundant myxoid stroma, while the absence of MYC amplification indicates the benign nature of these tumors, highlighting the need for further research into their clinical implications.
Limitations:
Small sample size of 14 SCM cases may limit generalizability.
Lack of longitudinal data to assess the progression of SCM.
Potential biases inherent in retrospective analysis.
Conclusion:
PLAG1 rearrangements may play a role in the pathogenesis of SCM, warranting further investigation into cardiac myxoid tumors and their potential clinical applications.
